Pfizer moves for vaccine approval for ages 5 to 12
A move toward vaccination for young citizens ages 5 to 12 could open up a whole new level of protection from covid-19. The drugmaker Pfizer today asked the U.S. Food and Drug Admin…
A move toward vaccination for young citizens ages 5 to 12 could open up a whole new level of protection from covid-19. The drugmaker Pfizer today asked the U.S. Food and Drug Admin…